-
-
-
-
-
-
-
Innovus Pharma Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women
-
-
-
-
-
-
-
Innovus Pharma Announces the Approval of its RecalMax™ Product in Canada Indicated to Temporarily Relieve Symptoms of Mental Fatigue and Sensation of Weakness and Support Cognitive Functions Includi
-
-
-
-
-
-
-
Form S-1 INNOVUS PHARMACEUTICALS,
-
-
-
-
-
-
-
Innovus Pharma (INNV) Granted Medicare Reimbursement Approval for GlucoGorx Blood Glucose Monitoring System & GlucoGorx Blood Glucose Test Strip Products
-
-
-
-
-
-
-
Innovus Pharma Signs Purchase Agreement with “Showcase – The Home of the Hottest Trends” to Sell the Company’s Apeaz® Cream for the Relief of Arthritis Pain in Its 110 “Showcase” Retail S
-
-
-
-
-
-
-
Innovus Pharma Announces the Launch of Its Product AllerVarx™ in Canada for Allergic Rhinitis
-
-
-
-
-
-
-
Innovus Pharmaceuticals to Release Its First Quarter 2018 Financial Results on Monday, May 14, 2018
-
66,407 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

